Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

At our Pancreatic Cancer Center, we create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies.

Meet Our Doctors

Our Approach to Treating Pancreatic Cancer

Our Approach to Pancreatic Cancer Treatment

Diagnosis

Surgery

Chemotherapy & Targeted Drugs

Radiation Therapy

Clinical Trials and Research Studies

Phase 3

A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

Learn More

Phase 3

PANOVA-3: Pivotal randomized open-label study of Tumor Treating Fields (TTFields 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma

Learn More

Phase 1

A phase I open-label dose-escalation study to investigate the safety pharmacokinetics pharmacodynamics and clinical activity of GSK3368715 in participants with solid tumors and DLBCL

Learn More

Phase 2

A Randomized Phase 2 Study of Losartan and Nivolumab in Combination with FOLFIRINOX and SBRT in Localized Pancreatic Cancer (Stand up to Cancer)

Learn More

View All Related Clinical Trials (10)